Sensus Healthcare Inc.
Sensus Healthcare Inc. (SRTS): 4 pipeline candidates · ~21 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
20.5 months
D/E 0.13 · 0% dilution
Lead: Approved
4 candidates
N/A
2 buys · 0 sells (180d)
A transparent, data-derived signal for Sensus Healthcare Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$44.6M
Cash
$18.3M
Quarterly Burn
$3.8M
Runway
20.5 mo
Revenue
$3.4M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| srt-100 | Approved |
| srt-100 vision | Approved |
| srt-100+ | Approved |
| transdermal infusion | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
39
Total value held
$12.0M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,296,450 | $5.2M |
| dimensional fund advisors lp | 387,392 | $1.5M |
| renaissance technologies llc | 252,234 | $1.0M |
| geode capital management, llc | 165,550 | $659K |
| meros investment management, lp | 152,418 | $607K |
| north star investment management corp. | 125,586 | $500K |
| bank of new york mellon corp | 100,410 | $400K |
| vanguard fiduciary trust co | 75,730 | $301K |
| blackrock, inc. | 71,167 | $283K |
| state street corp | 69,252 | $276K |
Showing top 10 of 39 institutional holders of Sensus Healthcare Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Sensus Healthcare Inc.'s pipeline?
Sensus Healthcare Inc. (SRTS) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Sensus Healthcare Inc.'s lead drug candidate?
Sensus Healthcare Inc.'s most advanced tracked candidate is srt-100 (Approved) for non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids.
What is Sensus Healthcare Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Sensus Healthcare Inc. has approximately 20.5 months of cash runway.
What is Sensus Healthcare Inc.'s market capitalization?
Sensus Healthcare Inc.'s market capitalization is approximately $44.6M.
Who is the CEO of Sensus Healthcare Inc.?
Mr. Joseph C. Sardano is the chief executive officer of Sensus Healthcare Inc. (SRTS).
Get the full picture on Sensus Healthcare Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.